BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 30951542)

  • 1. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
    Nishizawa K; Yoda N; Morokado F; Komori H; Nakanishi T; Tamai I
    PLoS One; 2019; 14(4):e0214862. PubMed ID: 30951542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high uric acid on the disposition of metformin: in vivo and in vitro studies.
    Zhang G; Ma Y; Xi D; Rao Z; Sun X; Wu X
    Biopharm Drug Dispos; 2019 Jan; 40(1):3-11. PubMed ID: 30488476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
    Shi R; Xu Z; Xu X; Jin J; Zhao Y; Wang T; Li Y; Ma Y
    Eur J Pharm Sci; 2019 Jan; 127():282-290. PubMed ID: 30428337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
    Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
    J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney.
    Ito S; Kusuhara H; Yokochi M; Toyoshima J; Inoue K; Yuasa H; Sugiyama Y
    J Pharmacol Exp Ther; 2012 Feb; 340(2):393-403. PubMed ID: 22072731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.
    Meyer zu Schwabedissen HE; Verstuyft C; Kroemer HK; Becquemont L; Kim RB
    Am J Physiol Renal Physiol; 2010 Apr; 298(4):F997-F1005. PubMed ID: 20053795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal vectorial transport of berberine mediated by organic cation transporter 2 (OCT2) and multidrug and toxin extrusion proteins 1 (MATE1) in rats.
    Shi R; Yang Y; Xu Z; Dai Y; Zheng M; Wang T; Li Y; Ma Y
    Biopharm Drug Dispos; 2018 Jan; 39(1):47-58. PubMed ID: 29065218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury.
    Matsuzaki T; Morisaki T; Sugimoto W; Yokoo K; Sato D; Nonoguchi H; Tomita K; Terada T; Inui K; Hamada A; Saito H
    Drug Metab Dispos; 2008 Apr; 36(4):649-54. PubMed ID: 18180268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased activity of basolateral organic ion transports in hyperuricemic rat kidney: roles of organic ion transporters, rOAT1, rOAT3 and rOCT2.
    Habu Y; Yano I; Takeuchi A; Saito H; Okuda M; Fukatsu A; Inui K
    Biochem Pharmacol; 2003 Sep; 66(6):1107-14. PubMed ID: 12963498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
    Müller F; König J; Hoier E; Mandery K; Fromm MF
    Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of OCT2 and MATE1 for the Cimetidine-Metformin Interaction: Insights from Investigations of Polarized Transport in Single- And Double-Transfected MDCK Cells with a Focus on Perpetrator Disposition.
    Müller F; Weitz D; Mertsch K; König J; Fromm MF
    Mol Pharm; 2018 Aug; 15(8):3425-3433. PubMed ID: 29975542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mangiferin promotes uric acid excretion and kidney function improvement and modulates related renal transporters in hyperuricemic mice].
    Hu QH; Zhang X; Wang Y; Kong LD
    Yao Xue Xue Bao; 2010 Oct; 45(10):1239-46. PubMed ID: 21348301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restored expression and activity of organic ion transporters rOAT1, rOAT3 and rOCT2 after hyperuricemia in the rat kidney.
    Habu Y; Yano I; Okuda M; Fukatsu A; Inui K
    Biochem Pharmacol; 2005 Mar; 69(6):993-9. PubMed ID: 15748710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).
    Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MATE1 rs2289669 polymorphism affects the renal clearance of metformin following ranitidine treatment.
    Cho SK; Chung JY
    Int J Clin Pharmacol Ther; 2016 Apr; 54(4):253-62. PubMed ID: 26784938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Aspects of Drug-Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K).
    Saad AAA; Zhang F; Mohammed EAH; Wu X
    Biol Pharm Bull; 2022; 45(4):382-393. PubMed ID: 35370262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.
    Kimura N; Masuda S; Tanihara Y; Ueo H; Okuda M; Katsura T; Inui K
    Drug Metab Pharmacokinet; 2005 Oct; 20(5):379-86. PubMed ID: 16272756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2K.
    Xiao G; Rowbottom C; Boiselle C; Gan LS
    Pharm Res; 2018 Jun; 35(8):159. PubMed ID: 29915999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice.
    Wang CP; Wang X; Zhang X; Shi YW; Liu L; Kong LD
    J Pharm Pharm Sci; 2010; 13(3):411-27. PubMed ID: 21092713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine.
    Müller F; Weitz D; Derdau V; Sandvoss M; Mertsch K; König J; Fromm MF
    Mol Pharm; 2017 Sep; 14(9):2991-2998. PubMed ID: 28708400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.